SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure following an orbital anomaly during a Blue Origin launch that resulted in the loss of a satellite. While the company confirmed that insurance will cover the loss and that production of upcoming units remains on track, investors are expressing deep concern over potential timeline delays and the reliability of launch partners.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is trending as traders closely monitor escalating geopolitical tensions in the Middle East alongside conflicting headlines regarding potential peace talks. Market participants are actively debating whether this volatility signals an impending pullback from recent highs or if algorithmic buying and tech earnings momentum will continue to drive a melt-up.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical Ltd. (PBM) is experiencing significant volatility and trading momentum driven by speculation surrounding a potential executive order aimed at fast-tracking psychedelic research for veteran mental health. Investors are heavily focused on the stock's low float and potential for a short squeeze, leading to heated discussions between bullish retail traders anticipating triple-digit price action and skeptical bears warning of a possible pump-and-dump scenario.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors monitor significant developments in the rare earths supply chain, including new commercial yttrium metal production and ongoing discussions regarding government funding and critical mineral trade agreements. The community is actively debating the company's valuation, potential technical breakout patterns, and the impact of geopolitical factors on domestic production capabilities.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is currently trending following an update on the open-label arm of its FLAMINGO-01 Phase III trial, which demonstrated a recurrence rate of less than 1% annually, representing a significant reduction compared to historical benchmarks. Investors are heavily focused on the company's progress toward the 14-event interim analysis and the upcoming AACR meeting, where a steering committee-backed abstract is expected to provide deeper insights into the drug's clinical efficacy.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as market sentiment surges following news that the White House issued an executive order to expedite psychedelic research and FDA review pathways. The community is actively discussing the stock's positioning as a late-stage clinical leader, with many investors debating the potential for an accelerated regulatory approval process to reshape the mental health sector.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently a focal point for the trading community, fueled by speculative interest in a potential strategic partnership with POSCO and ongoing debate over the impact of US steel tariffs on domestic production. Investors are closely monitoring price action as the community weighs the company's heavy debt load and recent insider selling against the bullish potential for a short squeeze and long-term industrial demand.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as community members closely monitor the upcoming AACR poster presentation for SLS009 and anticipate a final data readout for the REGAL Phase 3 trial. Long-term investors are expressing high confidence in the potential for a functional cure, while the stock is seeing significant volatility driven by intense debate over short interest levels and options positioning.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors monitor high trading volume and potential catalysts related to the companys global expansion in Japan and the Middle East, while community members actively discuss the long-term potential of the Anktiva platform to disrupt the oncology sector. Conversations are heavily focused on the contrast between the stock's clinical progress and the regulatory scrutiny from the FDA, with many shareholders maintaining conviction in the companys pipeline despite ongoing short-term market volatility.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


kqbd247site

KQBD 247 Site